. Quantification of the toxicity induced by phenolic compounds in 3T3-L1 preadipocytes. Results are expressed as the mean cell viability in percentage (±SD) relative to DMSO-treated control cells. Shadowed are the concentrations at which a significant decrease in cell viability is observed. Table S4 . Interactions of each phenolic compound with the specific amino acids of the PPARγ LBD, predicted by DockingServer (H for hydrogen, C for carbon and O for oxygen). Troglitazone and aglycones from naringin and hesperidin (naringenin and hesperetin, respectively) are shown shadowed for comparative purposes. 
Hydrogen bonds
Polar Cation-pi Hydrophobic pi-pi Other Troglitazone O-LYS265 (N)[3.38] C-HIS266 (CD2) [3.51] O-LEU228 (CB,CD2) [3.39] C-LEU228 (CD2) [3.74] N-LEU228 (CD2) [3.43] C-LEU333 (CD1) [3.89] H-LEU228 (CD2) [2.89] C-PHE287 (CD1) [3.75] C-HIS266 (NE2) [3.49] O-PHE287 (CD1) [3.89] C-ARG288 (CG) [3.78] C-GLU291 (CD,OE1,OE2) [2.85] S-GLU291 (OE2) [3.62] H-LEU333 (CD1) [3.84] O-LEU333 (CD1) [3.76] Hesperetin O-GLU291 (OE1) [3.62] H-PHE264 (CB, CD1, CG) [3.49] C-HIS266 (CD2) [3.64] O-PHE264 (CB, CD1, CG) [3.65] H-GLU291 (OE1, OE2) [3.29] H-HIS266 (CD2, CG) [2.87] C-LEU333 (CD1) [3.60] O-HIS266 (CD2) [3.35] C-ILE341 (CB,CG2) [3.56] H-GLU291 (CG) [3.67] O-LEU330 (CD1) [3.78] O-LEU333 (CD1) [3.39] H-LEU333 (CD1) [3.47] O-VAL339 (CG2) [3.67] H-VAL339 (CG2) [2.95] O-ILE341 (CB,CG2) [3.60] Luteolin O-ARG280 (CB, NH2) [3.42] O-GLU259 (OE2) [3.25] C-LEU255 (CD1) [3.80] C-PHE264 (CB, CD2, CG) [3.31] H-LEU255 (CD1, CD2, CG) [2.94] O-CYS285 (SG) [3.29] H-GLU259 (OE2) [2.29] C-CYS285 (SG) [3.82] C-HIS266 (CB, CD2, CG) [3.06] O-LEU255 (CD1, CD2) [3.37] H-ARG280 (CZ, NE, NH2) [3.36] C-ILE341 (CG2) [3.86] H -GLU259 (CD) [3.33] O-ARG288 (CB) [3.53] C-GLU259 (OE2) [
